WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 14'0601 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 22'3161 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 17'910  17'763  17'614  17'463  17'310  15'263  13'242  11'266 
Births 238  239  240  241  242  259  290  263 
Surviving infants 236  237  238  239  241  256  286  255 
Pop. less than 5 years 1'184  1'197  1'207  1'221  1'235  1'319  1'429  1'244 
Pop. less than 15 years 3'682  3'701  3'721  3'746  3'772  4'139  3'971  3'798 
Female 15-49 years 4'566  4'558  4'550  4'537  4'520  4'077  3'547  2'892 

Number of reported cases

(Click for retrospective incidence data for Chile)
Diphtheria
ChartChart
  36  253 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'958  3'844 
Mumps
ChartChart
  1'265  1'346  863  821  876  2'352 
Pertussis
ChartChart
  752  734  1'125  1'964  5'762  3'554  59  2'795 
Polio*
ChartChart
 
Rubella
ChartChart
  743 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  11  10  22  31 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chile)
Vaccine year result method % card seen                                                
BCG          97  93  98  98  92  93  94  96 
DTP1          99  97  99  92  90  98 
DTP3          95  96  95  91  90  91  95  93 
DTP4          88  90  90 
IPV1         
HepB_BD         
HepB3          95  96  95  90  90 
Hib3          95  96  95  90  90  91 
JapEnc         
MCV1          93  96  97  90  90  97  97  94 
MCV2          87  89  88  78  74 
MenA          96 
PCV1          99  97  98  92  90 
PCV2          97  96  96  91  90 
PCV3          90  92  79  82 
Pol3          95  96  95  90  90  91  95  93 
Rota1         
RotaC         
RCV1          93  96  97  90  90 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chile)
BCG
  97  93  98  98  92  93  94  96 
DTP1
  99  97  99  92  90  98  98  97 
DTP3
  95  96  95  91  90  91  95  93 
HepB3
  95  97  95  90  90 
HepB_BD
 
Hib3
  95  97  95  90  90  91 
IPV1
 
MCV1
  93  96  97  90  90  97  97  94 
MCV2
  87  89  88  78  74 
PCV3
  90  90  92  79  82 
Pol3
  95  96  95  90  90  91  95  93 
RCV1
  93  96  97  90  90  97  97 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 346  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 78
From 80 to 89% 16
From 50 to 79% 4
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HepA 18 months; No
HPV 9, 10 years; Yes
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, health care workers, pregnant women and other risk groups
Influenza_Pediatric 6-71 months; Yes and children with chronic diseases
IPV 2 months; Yes
MenACWY 1 year; Yes
MMR 1, 6 years; Yes
OPV 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 12 months; Yes in the metropolitain regon, the schedule is 2, 4, 6, 18 months
Pneumo_ps 65 years; Yes
Tdap 6, 13 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2010-2020  2010 2020  2010-2020      2'011   
Nº of districts with microplans that include activities to raise immunization coverage number 15         

System performance

Total Nº districts in country number 346  345    345  346  346   
Nº districts with DTP3 coverage >=80% number 326  252  246    170  238  293 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  73      49  69   
Nº districts with measles (MCV1) coverage >=95% number 192  90  143    84  105  163 
% of districts with MCV1 coverage >=95% From 0 to 100% 55  26      24  30   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes    No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.